Executive Summary

Overview:

As the CEO of Sunflower Nutraceuticals (SNC), a distributor of dietary supplements in multiple phases over 10 simulated years, you considered investment opportunities in revenue and EBIT (earnings before interest and taxes) growth and cash flow improvements. The firm operates on thin margins with a constrained cash position and limited credit. Use the income statement, balance sheet, and statement of cash flows to analyze the effects of each opportunity on working capital. The goal is to choose opportunities that add the most value to the firm as well as balance the desire for growth while maintaining sufficient liquidity.

Instructions:

As the CEO, you ran the simulation to evaluate various scenarios to increase revenue and cash flow. Provide an executive summary with the following:

? The audience is the company's Board of Directors as well as executive loan officers representing the financial institutions providing credit to Sunflower Nutraceuticals.

? Include any charts and/or tables that aid in the illustration of the process and results for the suggested options to achieve your stated results.

? Provide enough details on the selection of variables used in the simulation.

? The body will be a narrative with supportive labeled figures or charts describing in detail the business development in the designated periods.

? Multiple pages

Link: https://hbsp.harvard.edu/coursepacks/834302 - In the simulation screen, click on "View" in the text box that opens up (see attachment below). Try using Microsoft Edge or I.E or Google Chrome

ID: ngam dot voma at students.post.edu

Password: Jilaku#76

HARVARD BUSINESS WORKING CAPITAL SIMULATION: MANAGING GROWTH PUBLISHING PREPARE O ANALYZE: Dashboard Balance Sheet Income Cash Flow Cash Cyde Synopsis 2 Statement DECIDE: Welcome to the Working Capital Simulation click Here Choose a Saved Run to Continue Sunflo SUNFLOWER NUTRACEUTICALS Miami, Date Scenario Completed Total Firm Value consun and he 07/10/21 6:33 PM Non-binding Credit Limit Yes $4,030 View larize yourself with the basic background of and caf load the Terminology Primer to review key from more than 50 third-party brands. Since its founding, the c imulation. private-label brands, including a line of women's electrolyte sp Its SNC is breaking even, with relatively flat annual sales growth margins are generally thin. Several times during the past few ort the company's historical and current financial constrained cash position, and more than once the company's condition of Sunflower Nutraceuticals is changing to meet operational needs and this level of required cash is 5: of governing covenants, issued by a national bank. The credit 18 It is currently set at a rate of 8%. SNC uses a cost of capital of ter investment decisions for the next phase. You Health food companies have sold vitamins for decades, but thi ect any or all of the opportunities available to you stricter definitions, the term nutraceuticals generally means "a ou have finished entering your investment include omega-3 fatty acids, probiotics, and soy and energy dr ecision button to advance to the next phase. $128.6 billion; it is forecasted to grow at a compound annual g factors for industry growth are the increase in the elderly popu working population, and increasing societal awareness of prev Or Start a New Run d your financial statements to see how each opportunity you selected impacted Sunflower Nutraceutical's performance. WORKING CAPITAL SIMULATION: MANAGING GROWTH Continue until you have completed all phases of the simulation. More Details Non-binding Credit Limit